Skip to main content
Premium Trial:

Request an Annual Quote

Nuvelo, Orchid, Illumina, Oscient Among 26 Additions to Nasdaq Biotech Index

NEW YORK, May 18 (GenomeWeb News) - Several genomics companies, including Nuvelo, Orchid, Illumina, and Oscient (formerly Genome Therapeutics), were among 26 securities added to the Nasdaq Biotechnology Index yesterday.

The change in the index will become effective with the market open next Monday.

The Nasdaq stock market re-ranks the index every May and November based on minimum requirements for market value, average daily share volume, and other criteria.

A full list of the new firms added to the index is available here.